| Literature DB >> 34257358 |
Destaw Asfaw Ali1, Tesfaye Sisay Tesema2, Yosef Deneke Belachew3.
Abstract
Diarrheagenic Escherichia coli are a number of pathogenic E. coli strains that cause diarrheal infection both in animal and human hosts due to their virulence factors. A cross sectional study was conducted between November, 2016 and April, 2017 to isolate and molecularly detect pathogenic E. coli from diarrheic calves to determine the pathogenic strains, antibiogram and associated risk factors in Jimma town. Purposive sampling technique was used to collect 112 fecal samples from diarrheic calves. Conventional culture and biochemical methods were conducted to isolate E. coli isolates. Molecular method was followed to identify virulence factors of pathogenic E. coli strains. Antimicrobial sensitivity patterns of the isolates were tested using the Kirby-Bauer disk diffusion method. A structured questionnaire was also used to collect information from dairy farms and socio-demographic data. The overall isolation rate of E. coli in calves was 51.8% (58/112) (95% CI 42.0-61.0). The occurrence of the bacterium differed significantly by age, colostrum feeding time, amount of milk given per time and navel treatment (P < 0.05). Multivariable analysis revealed that the odds of being infected was significantly highest in calves which fed 1-1.5 L amount of milk per a time (OR 5.38, 95% CI 1.66-17.45, P = 0.005). The overall virulence genes detection rate was 53.5% (95% CI 40.0-67.0). Eleven (19.6%) of eaeA, 6 (10.7%) of Stx1 and 13 (23.2%) of Stx2 genes were detected from calves isolates. Except ciprofloxacillin, all isolates were resistant to at least one drug. Multi drug resistance was recorded in 68.0% (38/56) of calves isolates. Neomycin, 83.3% (25/30), followed by amoxicillin, 53.3% (16/30) were the highest resisted virulence genes. The study demonstrated considerable isolation rate, multiple antimicrobial resistant isolates and high resistant virulent genes in diarrheic calves. It also indicated that the potential importance of calves as source of pathogenic E. coli strains and resistant genes for human diarrhea infection. Improving the hygienic practice of farms and wise use of antimicrobials could help to reduce the occurrence of pathogenic E. coli in farms. Hence, further studies are needed to describe all virulent factors and serotypes associated with the emergence of drug resistant pathogenic E. coli strains in calves.Entities:
Year: 2021 PMID: 34257358 PMCID: PMC8277816 DOI: 10.1038/s41598-021-93688-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Over all occurrence of E. coli isolates with different factors in diarrheic calves.
| Variables | Category | Number examined | Number positive | Category proportion (%) | Samples proportion (%) | χ2 | |
|---|---|---|---|---|---|---|---|
| Age(week) | 1–2 | 44 | 33 | 75.0 | 29.5 | 16.31 | 0.001 |
| 3–8 | 39 | 16 | 41.0 | 14.3 | |||
| 9–16 | 29 | 9 | 31.1 | 8.0 | |||
| Sex | Female | 89 | 49 | 55.0 | 43.8 | 1.86 | 0.177 |
| Male | 23 | 9 | 39.1 | 8.0 | |||
| Breed | Cross | 94 | 48 | 51.1 | 42.9 | 0.398 | 0.390 |
| Local | 18 | 10 | 55.6 | 8.9 | |||
| FCFT | > 6 h | 20 | 16 | 80.0 | 14.3 | 5.26 | 0.027 |
| < 6 h | 92 | 42 | 45.7 | 37.5 | |||
| CF | Same barn | 66 | 37 | 56.1 | 33.0 | 1.18 | 0.279 |
| Separated | 46 | 21 | 45.7 | 18.8 | |||
| AMGPT | 1–1.5 L | 49 | 37 | 75.5 | 33.1 | 20.66 | 0.001 |
| 1.5–2.5 L | 33 | 9 | 27.3 | 8.0 | |||
| Unknown | 30 | 12 | 40.0 | 10.7 | |||
| Navel treatment | No | 54 | 35 | 64.8 | 31.3 | 7.09 | 0.008 |
| Yes | 58 | 23 | 39.7 | 20.5 | |||
| Each total | 112 | 51.8 |
FCFT first colostrum feeding time, AMGPT amount of milk given per time, CF calving facility; χ Chi square, P probability.
Risk factors associated with E. coli isolates in calves by univariable and multivariable logistic regression.
| Risk factors | Category | No. tested | Sample positive (%) | Univariable | Multivariable | ||
|---|---|---|---|---|---|---|---|
| COR(CI) | AOR(CI) | ||||||
| Age (weeks) | 1–2 | 44 | 33 (29.5) | 6.66 (2.35–18.89) | 0.001 | 4.029 (1.22–13.27) | 0.022 |
| 3–8 | 39 | 16 (14.3) | 1.55 (0.56–4.26) | 0.399 | 0.968 (0.28–3.31) | 0.954 | |
| 9–16 | 29 | 9 (8.0) | 1.00 | 1.00 | |||
| Sex | Female | 89 | 49 (43.8) | 1.91 (0.75–4.86) | 0.177 | 2.55 (0.79–82.13) | 0.116 |
| Male | 23 | 9 (8.0) | 1.00 | 1.00 | |||
| Breed | Cross | 94 | 48 (42.9) | 0.64 (0.23–1.78) | 0.390 | – | – |
| Local | 18 | 10 (8.9) | 100 | – | |||
| FCFT | > 6 h | 20 | 16 (14.3) | 3.41 (1.15–10.19) | 0.027 | 3.73 (1.01–13.76) | 0.048 |
| < 6 h | 92 | 42 (37.5) | 1.00 | 1.00 | |||
| CF | The same barn | 66 | 37 (33.0) | 1.51 (0.72–3.24) | 0.279 | – | – |
| Separated pen | 46 | 21 (18.8) | 1.00 | – | |||
| AMGPT | 1–1.5 L | 49 | 37 (33.1) | 4.63 (1.74–12.30) | 0.002 | 5.38 (1.66–17.45) | 0.005 |
| 1.5–2.5 L | 33 | 9 (8.0) | 0.56 (0.19–1.62) | 0.287 | 0.73 (0.20–2.84) | 0.631 | |
| Unknown | 30 | 12 (10.7) | 1.00 | 1.00 | |||
| Navel treatment | No | 54 | 35 (31.3) | 2.80 (1.30–6.04) | 0.008 | 1.93 (0.75–4.94) | 0.173 |
| Yes | 58 | 23 (20.5) | 1.00 | 1.00 | |||
COR crude odd ratio, AOR adjusted odd ratio, CF calving facility, AMGPT amount of milk given per time, CI confidence interva, P probability, 1.00 rreference group.
PCR detection rate of virulence genes in E. coli isolates in diarrheic calves and children.
| Sample source | Genes | Isolates examined | Positive isolates (%) | Diarrheic samples (%) | χ2 | |
|---|---|---|---|---|---|---|
| Calves | 56 | 11 (19.6) | 11 (9.8) | 11.86 | 0.001 (0.000–0.052) | |
| 56 | 6 (10.7) | 6 (5.4) | 5.82 | 0.016 (0.00–0.113) | ||
| 56 | 13 (23.2) | 13 (11.6) | 14.67 | 0.001 (0.000–0.052) | ||
| Total | 30 (53.5) | 30 (26.8) |
χ Chi square, P Probability, CI confidence interval.
Figure 1(A–C) Amplification of virulence genes in E. coli isolates from diarrheic calves and the images are a product of time averaged data. M marker, N negative control, P positive control; Numbers = 1–11 representative sample numbers; (A) eaeA gene with 450 bp; (B) stx2 gene with 350 bp; (C) stx1 gene with 110 bp.
Number (%) of E. coli isolates (56) resistant to antimicrobials.
| Antibiotics | Susceptible (%) | Intermediate (%) | Resistant (%) |
|---|---|---|---|
| Amoxacillin | 26 (46.4) | 3 (5.4) | 27 (48.2) |
| Chloramphenicol | 50 (89.3) | 5 (8.4) | 1 (1.8) |
| Ciprofloxacillin | 55 (98.2) | 1 (1.8) | – |
| Cefoxitin | 41 (73.2) | 10 (17.9) | 5 (8.9) |
| Gentamycin | 53 (94.6) | 1 (1.8) | 2 (3.6) |
| Neomycin | 4 (7.1) | 9 (16.1) | 43 (76.8) |
| Norfloxacillin | 55 (98.2) | – | 1 (1.8) |
| Oxytetracycliine | 41 (73.2) | – | 15 (26.8) |
| Streptomycin | 44 (78.6) | 7 (12.5) | 5 (8.9) |
| Sulfonamides | 30 (53.6) | 4 (7.1) | 22 (39.3) |
| Trimethoprim | 35 (62.5) | 1 (1.8) | 20 (35.7) |
| Total (%) | 434 (70.45) | 41 (6.65) | 141 (22.9) |
Multiple antimicrobial resistance profiles of E. coli isolates.
| Number of antimicrobials | Isolates from calves (n = 56) | |
|---|---|---|
| Resistance pattern (no. of isolates) | No. of isolates (%) | |
| Two | NEO, AMC (7); W, AMC (3); AMC, S3 (1); W, S3 (2); NEO, S3 (1); NEO, OT (1) | 15 (26.8) |
| Three | NEO, AMC, S3 (1); W, AMC, S3 (1); NEO, W, AMC (2); NEO, OT, S3 (2); NEO, AMC, OT (1); S, W, S3 (1) | 8 (14.3) |
| Four | NEO, AMC, OT, CXT (1); NEO, W, AMC, S3 (2); NEO, AMC, CXT, S3 (1); NEO, AMC, OT, S3 (2); NEO, W, OT, S3 (3) | 9 (16.1) |
| Five | W, AMC, OT, CXT, S3 (1); NEO, W, AMC, OT, S3 (1) | 2 (3.6) |
| Six | NEO, S, W, AMC, OT, S3 (1); GEN, NEO, S, W, CXT, S3 (1) | 2 (3.6) |
| Seven | GEN, NEO, W, AMC, OT, CHL, S3 (1) | 1 (1.8) |
| Eight | NEO, S, W, AMC, OT, CXT, NOR, S3 (1) | 1 (1.8) |
| Total | 38 (67.8) | |
AMC Amoxacillin, CHL Chloramphenicol, CPR Ciprofloxacillin, CXT Cefoxitin, GEN Gentamycin, NEO Neomycin, NOR Norfloxacillin, OT Oxytetracycliine, S Streptomycin, S3 Sulfonamides, W Trimethoprim.
Antimicrobial resistance profiles of pathogenic E. coli strains genes (n = 30).
| Antimicrobials | Resistant level of Pathogenic strain harboring virulence factor genes (%) | |||
|---|---|---|---|---|
| All (n = 30) | ||||
| Amoxacillin | 5 (45.5) | 1 (16.6) | 10 (76.9) | 16 (53.3) |
| Chloramphenicol | – | – | – | – |
| Ciprofloxacillin | – | – | – | – |
| Cefoxitin | – | – | 3 (23.1) | 3 (10) |
| Gentamycin | – | – | – | – |
| Neomycin | 9 (81.8) | 4 (66.6) | 12 (92.3) | 25 (83.3) |
| Norfloxacillin | – | – | 1 (7.7.) | 1 (3.3) |
| Oxytetracycliine | 3 (27.3) | 1 (16.6) | 3 (23.1) | 7 (23.3) |
| Streptomycin | 2 (18.2) | – | 1 (7.7) | 3 (10) |
| Sulfonamides | 3 (27.3) | 2 (33.3) | 5 (38.5) | 10 (33.3) |
| Trimethoprim | 3 (27.3) | 2 (33.3) | 3 (23.1) | 8 (26.7) |
n number.
Figure 2Map of the study area. (Generated by Destaw A. Ali using QGIS 2.18 software. https://qgis.org/en/site/forusers/visualchangelog218/index.html.
Primer gene sequence and PCR conditions.
| Nucleotide sequence | Target Gene | PCR condition (35 cycles) | Product size (bp) | References | |||
|---|---|---|---|---|---|---|---|
| Denaturing | Annealing | Extension | |||||
| EAEF | 5′-AAACAGGTGAAACTGTTGCC-3′ | 95 °C, 60 s | 55 °C,60 s | 72 °C,60 s | 450 | [ | |
| EAER | 5′-CTCTGCAGATTAACCTCTGC-3′ | ||||||
| EVSF | 5′-ATCAGTCGTCACTCACTGGT-3′ | 95 °C, 60 s | 55 °C,60 s | 72 °C,60 s | 110 | [ | |
| EVCR | 5′-CTGCTGTCACAGTGACAAA-3′ | ||||||
| EVTF | 5′-CAACACTGGATGATCTCAG-3′ | 95 °C, 60 s | 55 °C,60 s | 72 °C,60 s | 350 | [ | |
| EVTR | 5′-CCCCCTCAACTGCTAATA-3′ | ||||||
F Forward, R Reverse, eae effacing and attaching, ev Verocytotoxin, stx shiga toxin, bp base pair.